{
  "resourceType": "CodeSystem",
  "id": "shr-oncology-HER2ISHMethodCS",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p><b>SHR HER2ISHMethodCS CodeSystem</b></p>\n<p>Value set containing In Situ Hybridization methods of determining HER2 status</p>\n</div>"
  },
  "url": "http://standardhealthrecord.org/shr/oncology/cs/HER2ISHMethodCS",
  "identifier": {
    "system": "http://standardhealthrecord.org",
    "value": "shr.oncology.HER2ISHMethodCS"
  },
  "version": "0.1.0",
  "name": "HER2ISHMethodCS",
  "title": "SHR HER2ISHMethodCS CodeSystem",
  "status": "draft",
  "date": "2018-08-22T00:00:00-04:00",
  "publisher": "The MITRE Corporation: Standard Health Record Collaborative",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://standardhealthrecord.org"
        }
      ]
    }
  ],
  "description": "Value set containing In Situ Hybridization methods of determining HER2 status",
  "caseSensitive": true,
  "content": "complete",
  "count": 2,
  "concept": [
    {
      "code": "single",
      "display": "HER2 by Single Probe Assay In Situ Hybridization test",
      "definition": "HER2 by Single Probe Assay In Situ Hybridization test"
    },
    {
      "code": "dual",
      "display": "HER2 by Dual Probe Assay In Situ Hybridization test",
      "definition": "HER2 by Dual Probe Assay In Situ Hybridization test"
    }
  ]
}